1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Saul Centers reported fourth quarter 2024 results on February 28, 2025. Total revenue rose to $67.9 million from $66.7 million, but net income fell to $10.4 million from $17.5 million, and FFO per diluted share fell to $0.63 from $0.79. The company attributed the profit decline mainly to initial operations at Twinbrook Quarter Phase 1, which began carrying interest, taxes and other costs as expenses after its October 1, 2024 delivery, along with lower lease termination fees.
Q4 2024 total revenue was $67.9 million, up from $66.7 million in Q4 2023.
Net income available to common stockholders was $5.3 million, or $0.22 per basic and diluted share, versus $10.4 million, or $0.43, a year earlier.
Twinbrook Quarter Phase 1 reduced quarterly net income by $6.8 million compared with the prior-year quarter.
Lower lease termination fees of $2.4 million reduced results; commercial portfolio was 95.2% leased at December 31, 2024, up from 94.1%.
Amneal reported fourth-quarter and full-year 2024 results on February 28, 2025. Net revenue rose 18% in the quarter and 17% for the year, while the GAAP net loss narrowed in the quarter but widened for the full year, and adjusted diluted EPS declined. The company also gave 2025 guidance for net revenue of $3.0 billion to $3.1 billion and adjusted EBITDA of $650 million to $675 million.
Q4 2024 net revenue was $731 million, up 18% from $617 million; GAAP net loss attributable to Amneal was $31 million, versus $99 million in Q4 2023.
Q4 2024 adjusted diluted EPS was $0.12, compared with $0.14 in Q4 2023.
Full-year 2024 net revenue was $2.79 billion, up 17%; GAAP net loss was $117 million, versus $84 million in 2023; adjusted diluted EPS was $0.58, down 9%.
2025 guidance: net revenue of $3.0 billion to $3.1 billion, adjusted EBITDA of $650 million to $675 million, and adjusted diluted EPS of $0.65 to $0.70.
AES reported full-year 2024 net income of $698 million, up from a net loss of $182 million in 2023, and Adjusted EPS of $2.14, above its $1.87 to $1.97 guidance range. Adjusted EBITDA fell $189 million to $2,639 million and total revenue declined to $12,278 million from $12,668 million, while the company initiated 2025 guidance for Adjusted EBITDA of $2,650 million to $2,850 million and Adjusted EPS of $2.10 to $2.26.
Full-year 2024 diluted EPS from continuing operations was $2.37, compared with $0.34 in 2023
Adjusted EBITDA was $2,639 million, within the $2,600 million to $2,900 million guidance range but down from $2,828 million in 2023
2025 guidance: Adjusted EBITDA of $2,650 million to $2,850 million and Adjusted EPS of $2.10 to $2.26
Quarterly dividend of $0.17595 expected to be maintained
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.